122 related articles for article (PubMed ID: 8683154)
1. The signaling activity of murine CD19 is regulated during cell development.
Krop I; Shaffer AL; Fearon DT; Schlissel MS
J Immunol; 1996 Jul; 157(1):48-56. PubMed ID: 8683154
[TBL] [Abstract][Full Text] [Related]
2. CD38 ligation in human B cell progenitors triggers tyrosine phosphorylation of CD19 and association of CD19 with lyn and phosphatidylinositol 3-kinase.
Kitanaka A; Ito C; Coustan-Smith E; Campana D
J Immunol; 1997 Jul; 159(1):184-92. PubMed ID: 9200454
[TBL] [Abstract][Full Text] [Related]
3. Role of CD19 tyrosine 391 in synergistic activation of B lymphocytes by coligation of CD19 and membrane Ig.
Li X; Sandoval D; Freeberg L; Carter RH
J Immunol; 1997 Jun; 158(12):5649-57. PubMed ID: 9190913
[TBL] [Abstract][Full Text] [Related]
4. Regulation of B lymphocyte development and activation by the CD19/CD21/CD81/Leu 13 complex requires the cytoplasmic domain of CD19.
Sato S; Miller AS; Howard MC; Tedder TF
J Immunol; 1997 Oct; 159(7):3278-87. PubMed ID: 9317126
[TBL] [Abstract][Full Text] [Related]
5. Differential induction of DNA-binding activities following CD19 cross-linking in human B lineage cells.
Weng WK; Shah N; O'Brien D; Van Ness B; LeBien TW
J Immunol; 1997 Dec; 159(11):5502-8. PubMed ID: 9548490
[TBL] [Abstract][Full Text] [Related]
6. Cross-linking CD21/CD35 or CD19 increases both B7-1 and B7-2 expression on murine splenic B cells.
Kozono Y; Abe R; Kozono H; Kelly RG; Azuma T; Holers VM
J Immunol; 1998 Feb; 160(4):1565-72. PubMed ID: 9469411
[TBL] [Abstract][Full Text] [Related]
7. Modulation of signaling via the B cell antigen receptor by CD21, the receptor for C3dg and EBV.
Luxembourg AT; Cooper NR
J Immunol; 1994 Nov; 153(10):4448-57. PubMed ID: 7525704
[TBL] [Abstract][Full Text] [Related]
8. Signaling through the EBV/C3d receptor (CR2, CD21) in human B lymphocytes: activation of phosphatidylinositol 3-kinase via a CD19-independent pathway.
Bouillie S; Barel M; Frade R
J Immunol; 1999 Jan; 162(1):136-43. PubMed ID: 9886379
[TBL] [Abstract][Full Text] [Related]
9. The CD19 complex of B lymphocytes. Activation of phospholipase C by a protein tyrosine kinase-dependent pathway that can be enhanced by the membrane IgM complex.
Carter RH; Tuveson DA; Park DJ; Rhee SG; Fearon DT
J Immunol; 1991 Dec; 147(11):3663-71. PubMed ID: 1719083
[TBL] [Abstract][Full Text] [Related]
10. Differential phosphorylation of functional tyrosines in CD19 modulates B-lymphocyte activation.
Ishiura N; Nakashima H; Watanabe R; Kuwano Y; Adachi T; Takahashi Y; Tsubata T; Okochi H; Tamaki K; Tedder TF; Fujimoto M
Eur J Immunol; 2010 Apr; 40(4):1192-204. PubMed ID: 20101619
[TBL] [Abstract][Full Text] [Related]
11. A truncated heavy chain protein relieves the requirement for surrogate light chains in early B cell development.
Shaffer AL; Schlissel MS
J Immunol; 1997 Aug; 159(3):1265-75. PubMed ID: 9233622
[TBL] [Abstract][Full Text] [Related]
12. Role of mu heavy chain in B cell development. I. Blocked B cell maturation but complete allelic exclusion in the absence of Ig alpha/beta.
Cronin FE; Jiang M; Abbas AK; Grupp SA
J Immunol; 1998 Jul; 161(1):252-9. PubMed ID: 9647231
[TBL] [Abstract][Full Text] [Related]
13. Activation of mitogen-activated protein kinases via CD40 is distinct from that stimulated by surface IgM on B cells.
Kashiwada M; Kaneko Y; Yagita H; Okumura K; Takemori T
Eur J Immunol; 1996 Jul; 26(7):1451-8. PubMed ID: 8766546
[TBL] [Abstract][Full Text] [Related]
14. CD19 regulates B lymphocyte signaling thresholds critical for the development of B-1 lineage cells and autoimmunity.
Sato S; Ono N; Steeber DA; Pisetsky DS; Tedder TF
J Immunol; 1996 Nov; 157(10):4371-8. PubMed ID: 8906812
[TBL] [Abstract][Full Text] [Related]
15. CD19 expression levels regulate B lymphocyte development: human CD19 restores normal function in mice lacking endogenous CD19.
Sato S; Steeber DA; Jansen PJ; Tedder TF
J Immunol; 1997 May; 158(10):4662-9. PubMed ID: 9144478
[TBL] [Abstract][Full Text] [Related]
16. Signaling through CD19, Fc receptors or transforming growth factor-beta: each inhibits the activation of resting human B cells differently.
Barrett TB; Shu GL; Draves KE; Pezzutto A; Clark EA
Eur J Immunol; 1990 May; 20(5):1053-9. PubMed ID: 1694130
[TBL] [Abstract][Full Text] [Related]
17. Signaling through surface IgM in tolerance-susceptible immature murine B lymphocytes. Developmentally regulated differences in transmembrane signaling in splenic B cells from adult and neonatal mice.
Yellen AJ; Glenn W; Sukhatme VP; Cao XM; Monroe JG
J Immunol; 1991 Mar; 146(5):1446-54. PubMed ID: 1847161
[TBL] [Abstract][Full Text] [Related]
18. Regulation of B lymphocyte activation by complement C3 and the B cell coreceptor complex.
Rickert RC
Curr Opin Immunol; 2005 Jun; 17(3):237-43. PubMed ID: 15886112
[TBL] [Abstract][Full Text] [Related]
19. The CD19/CD21 signal transducing complex of human B lymphocytes includes the target of antiproliferative antibody-1 and Leu-13 molecules.
Bradbury LE; Kansas GS; Levy S; Evans RL; Tedder TF
J Immunol; 1992 Nov; 149(9):2841-50. PubMed ID: 1383329
[TBL] [Abstract][Full Text] [Related]
20. Cutting edge: recruitment of the CD19/CD21 coreceptor to B cell antigen receptor is required for antigen-mediated expression of Bcl-2 by resting and cycling hen egg lysozyme transgenic B cells.
Roberts T; Snow EC
J Immunol; 1999 Apr; 162(8):4377-80. PubMed ID: 10201971
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
